Discover
RDNT
RadNet, Inc.
65.62
2 x 47.01
2 x 79.94
bid
ask
+
3.95
6.41%
2 @ 05:06 AM
65.52 -0.10 (0.15%)
| Ytd | -8.03% | |
| 1y | 17.92% |
61.83
day range
65.67
50.76
52 week range
85.84
| Open | 62.00 | Prev Close | 61.67 | Low | 61.83 | High | 65.67 | Mkt Cap | 5.16B |
| Vol | 1.01M | Avg Vol | 879.72K | EPS | -0.17 | P/E | N/A | Forward P/E | 69.56 |
| Beta | 1.39 | Short Ratio | 13.55 | Inst. Own | 100.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 56.26 | 200-d Avg | 67.83 | 1yr Est | 89.75 |
RDNT News
zacks.com
RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools
RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk
benzinga.com
Radnet's DeepHealth Unit Receives FDA 510(k) Clearances For Two New Breast Suite Functionalities
Breast Arterial Calcification (BAC) Assessment, a tool applied to standard screening mammograms that
globenewswire.com
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Int
SOMERVILLE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health
benzinga.com
Radnet Unit DeepHealth Launches Reporting Pro, An AI-Powered Tool For Generating Clinical Reports
Reporting Pro was introduced at RSNA 2025 and is now available for commercial deployment. Reporting